Skip to main content

Table 3 The univariate and multivariate analysis for post-procedural bleeding

From: Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis

 

Bleeding

No bleeding

Univariate (p value)

Multivariate OR

95 % CI

Multivariate (p value)

Age

72.2 ± 8.6

73.6 ± 8.5

0.40

0.26

0.01-9.30

0.45

Sex (M/F)

29/4

170/42

0.71

   

Anticoagulants vs. Antiplatelet drugsa

21:12

114:98

0.28

1.36

0.61-3.17

0.45

Number of antithrombotic drugs Multiple vs. singlea

21:12

112:100

0.25

1.88

0.84-4.38

0.12

Type of heparin

32:1

207:5

0.81

   

Unfractionated heparin vs. LMWH

Dose adjustment of HBT

17:16

36:176

<0.001

5.06

2.29-11.3

<0.001

Adjusted vs. Fixeda

Timing of antithrombotic resumption Appropriate vs. Inappropriate

16:17

119:93

0.51

   
  1. OR: odds ratio, CI: confidence interval, LMWH: low molecular- weight heparin, HBT: heparin bridge therapy
  2. aControl in multivariate analysis